Colgate-Palmolive Company

The full register, from 13F filings

The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 1,925 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.

Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.

What a reader needs to know to read these numbers

• shares_outstanding (797,172,829) is common stock as stated on the Q2 FY2026 Form 10-Q cover page, as of 30 Jun 2026 (filed 31 Jul 2026). Colgate has a single class of common stock, $1.00 par value, one vote per share: no dual-class structure and no founder control block.
• market_cap_usd (73.30bn) and market_cap_as_of (2026-08-14 close) are taken from stockanalysis.com, which independently reports shares outstanding of 797.17 million, consistent with the 10-Q cover-page figure, at a closing price of $91.95.
• Colgate-Palmolive Company holds a majority stake in Colgate-Palmolive (India) Limited, a company separately listed on the NSE (COLPAL) and BSE (500830) with a genuine public minority. This is recorded as the sole holdings entry. Exhibit 21.1 to the FY2025 10-K confirms the entity is 'not wholly owned' but states no percentage; the 51.00% figure and the entity-level share breakdown come from two independent secondary aggregators (Trendlyne, Screener.in), not a primary SEC or Indian-regulator filing fetched in this task, so basis is 'aggregator' / confidence 'reported' rather than 'filed'. Direction check: Colgate-Palmolive Company is the majority owner here, the reverse of the noncontrolling-interest line on Colgate's own balance sheet, which represents the India public float's (and other JVs') stake in Colgate, not a Colgate stake in anyone else.
• Exhibit 21.1 (List of Subsidiaries, FY2025 10-K) marks five further entities as 'not wholly owned, directly or indirectly, by Colgate-Palmolive Company' with no percentage disclosed: Colgate Tolaram Pte. Ltd. (Singapore), Colgate-Palmolive (Gulf States) Ltd. (UAE), Colgate-Palmolive ACI Bangladesh Pvt. Limited, Colgate-Palmolive Arabia Ltd. (Saudi Arabia), and Colgate-Palmolive Cameroun S.A. None of these is separately listed and none could be sized within this task's time budget, so none is recorded as a holdings row; see unknowns.
• The FY2025 10-K's Summary of Significant Accounting Policies states equity-method investments (20-50% interests in unrelated consumer products companies, unrelated third parties holding the remainder) totalled $82 million at 31 Dec 2025 and $81 million at 31 Dec 2024, included in Other assets. No investee is named anywhere in the 10-K or the Q2 FY2026 10-Q. Per the brief's rule that a combined balance covering several investees sizes none of them, this is not recorded as a holdings row; the combined figure is preserved here and in unknowns instead.
• Vanguard filed Form 13F-NT (notice, no holdings table) rather than 13F-HR for the quarters ended 31 Mar 2026 and 30 Jun 2026 under CIK 0000102909, so the register uses its last 13F-HR, for the quarter ended 31 Dec 2025 (filed 29 Jan 2026). This is the same pattern documented in the project's existing Broadcom file.
• The 2026 DEF 14A's own >5%-owner table cites older Schedule 13G/A figures that are staler than this register's 13F rows: Vanguard 82,189,533 shares (10.26%) as of 31 Jan 2025 per a 13G/A filed 7 Feb 2025; BlackRock 65,563,643 shares (8.18%) as of 30 Sep 2024 per a 13G/A filed 12 Nov 2024; State Street 47,641,721 shares (5.95%) as of 31 Dec 2023 per a 13G/A filed 25 Jan 2024. This research prefers the fresher 13F figures for the register per the brief's reconciliation rule; both sets of numbers are preserved here rather than overwritten.
• State Street Bank and Trust Company, a subsidiary of State Street Corporation, is named in the DEF 14A as trustee of the Colgate-Palmolive Company Employee Stock Ownership Plan. Whether the 6,646,688 ESOP shares (10-K, as of 31 Dec 2025) are included within State Street Corporation's Q2 2026 13F position of 47,020,966 shares, or reported separately because ESOP participants (not State Street) direct the investment decision, was not established in this task. Both rows are recorded at face value; summing every register row could therefore double count up to 6,646,688 shares.
• The register mixes several measurement dates: the nine 13F institutional rows are dated 31 Dec 2025 (Vanguard only) or 30 Jun 2026 (the other eight); the ESOP trust row is dated 31 Dec 2025 (10-K); the insider rows are dated 9 Mar 2026 (proxy record date). Do not sum pct_of_company across rows with different as_of dates without accounting for that.
• Self-check: summing every register row that is neither a proxy-aggregate member nor the aggregate itself (the 9 institutional 13F rows plus the ESOP trust row) gives 278,563,634 shares against 797,172,829 shares outstanding, or 34.9%, within the expected 15-55% band for a single-instrument, single-basis register.
• No em dashes are used in this file per house style.